بائیو ٹیکنالوجی اور اس کے اثرات، دینی و اخلاقی پہلو

Biotechnology has helped to improve the quality of people’s lives over ten thousand years. Today’s biotechnologies vary in application and over the last century, the number and range of biotechnologies have rapidly increased. A key to this increase was the discovery of the structure of DNA in 1953, leading to numerous applications, particularly in forensics, medicine and agriculture. There are some strong religious and ethical views and observations regarding the advancement of this technology. Biotechnology involving practices such as organ transplants, manipulating human embryos and using animal in research may be particularly offensive to some groups of people, while the fundamental aim of this technology is to meet human needs or demands to improve the quality of life. Ethics and Xenotransplantation, Ethics and Zebrafish, Ethics and organ donation and Designer Babies have become today’s controversial issues. This article aims to explore these issues and analyze as per religious ethical values and standards.  

The Effect of Saline Flush After Rocuronium Bolus on the Proportion of Patients With Excellent Intubating Conditions in Adult Patients Undergoing Elective Surgery at Akuh-N

Background: In emergency surgeries requiring endotracheal intubation, the time to effect of neuromuscular blocking drugs is a crucial time in which patients are predisposed to hypoxia and aspiration into the lungs. Various strategies have been undertaken to shorten this time, including the timing and the priming techniques, dose changes and use of a flush following the muscle relaxant. All these methods had positive results but some are associated with side effects. The effectiveness of a muscle relaxant can either be assessed using the train of four or intubating conditions on the Goldberg scale. In this study, the plan is to investigate the effects of a 20 ml saline bolus following intravenous rocuronium at 0.6 mg/kg on the proportions of patients with excellent intubating conditions at one minute. Methodology: Fifty-two patients were randomly allocated to the saline bolus group or the no saline flush group. Anaesthesia was induced using propofol and remifentanil via target-controlled infusion (TCI) and maintained with the same. Rocuronium 0.6 mg/kg intravenous (IV) was administered followed by a 20 ml saline flush in the study group compared to administration of 0.6 mg/kg rocuronium without a saline bolus in the control group. Intubation conditions were assessed using the Goldberg scale filled by the intubating doctor. The onset of neuromuscular block was assessed by the train of four T1 height depression with an accelerometer attached to the adductor pollicis muscle. Results: There were 25 patients in each group. Patients in both groups were comparable with respect to demographic profiles. In the group with a flush, 18(62.1%) patients had “excellent” and seven (33.3%) patients had “good” intubating conditions as opposed to 11 (37.9%) having “excellent” and 14 (66.7%) having “good” intubating condition in the group without a flush. The distribution of intubating conditions for the two groups showed a difference of 24.2% in the proportion of patients with excellent intubating conditions which was statistically significant (P=0.042). There was no association between twitch height at one minute and intubating conditions. Conclusion: In this group of patients studied, the administration of a 20 ml saline flush after 0.6mg/kg rocuronium significantly increases the proportion of patients with excellent intubating conditions as compared to rocuronium without a saline flush.